Kingdon Capital and Velan Capital’s Agreement with OptiNose for Board Representation

Olshan Frome Wolosky represented Kingdon Capital and Velan Capital in the matter.OptiNose AS (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now